ArticleFrontiers in immunology2022

Inhibition of PCSK9 enhances the antitumor effect of PD-1 inhibitor in colorectal cancer by promoting the infiltration of CD8

Rui Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.